We have located links that may give you full text access.
Detection of exudates in fundus photographs with imbalanced learning using conditional generative adversarial network.
Biomedical Optics Express 2018 October 2
Diabetic retinopathy (DR) is a leading cause of blindness worldwide. However, 90% of DR caused blindness can be prevented if diagnosed and intervened early. Retinal exudates can be observed at the early stage of DR and can be used as signs for early DR diagnosis. Deep convolutional neural networks (DCNNs) have been applied for exudate detection with promising results. However, there exist two main challenges when applying the DCNN based methods for exudate detection. One is the very limited number of labeled data available from medical experts, and another is the severely imbalanced distribution of data of different classes. First, there are many more images of normal eyes than those of eyes with exudates, particularly for screening datasets. Second, the number of normal pixels (non-exudates) is much greater than the number of abnormal pixels (exudates) in images containing exudates. To tackle the small sample set problem, an ensemble convolutional neural network (MU-net) based on a U-net structure is presented in this paper. To alleviate the imbalance data problem, the conditional generative adversarial network (cGAN) is adopted to generate label-preserving minority class data specifically to implement the data augmentation. The network was trained on one dataset (e_ophtha_EX) and tested on the other three public datasets (DiaReTDB1, HEI-MED and MESSIDOR). CGAN, as a data augmentation method, significantly improves network robustness and generalization properties, achieving F1-scores of 92.79%, 92.46%, 91.27%, and 94.34%, respectively, as measured at the lesion level. While without cGAN, the corresponding F1-scores were 92.66%, 91.41%, 90.72%, and 90.58%, respectively. When measured at the image level, with cGAN we achieved the accuracy of 95.45%, 92.13%, 88.76%, and 89.58%, compared with the values achieved without cGAN of 86.36%, 87.64%, 76.33%, and 86.42%, respectively.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app